Skip to content
Medx

Tag: Bydureon discontinuation

Explore our medication guides and pharmacology articles within this category.

What is equivalent to Bydureon? Understanding Alternatives After Discontinuation

•
5 min read
In late 2024, pharmaceutical company AstraZeneca discontinued Bydureon and Bydureon BCise, leaving many patients who relied on the once-weekly injection to seek new options. While there is no direct generic for the drug, known by its active ingredient extended-release exenatide, several other medications within the same class offer similar therapeutic benefits. Understanding **what is equivalent to Bydureon** is now essential for making a smooth and effective transition with a healthcare provider.

Is Bydureon FDA approved for weight loss?

•
2 min read
In late 2024, manufacturer AstraZeneca discontinued the once-weekly medication Bydureon. Despite causing modest weight loss as a side effect for some patients, Bydureon was never FDA approved for weight loss, and its primary indication was always for the management of type 2 diabetes.